Inclusion Criteria:

- Treatment for prostate cancer using hormonal ablation therapy

- Average of three or more hot flashes a day

- Performance Status (Karnofsky ≥ 60)

- Patients must be ≥ 18 years of age

- No other clinically significant disease

- Signed study-specific consent form prior to study entry

Exclusion Criteria:

- Initiation of a new chemotherapy regimen, immunotherapy; or initiation/ cessation of
hormonal therapy during the study or for 3 weeks before the start of the study

- Pharmacological treatment of hot flashes or use of selective serotonin reuptake
inhibitors (unless the dose and patients’ condition have been stable for 4 weeks)

- Skin infections

- Patients who had acupuncture treatment in the 6 weeks prior to entering the study, or
acupuncture given specifically for the treatment of hot flashes in the previous 6
months.